Bluejay Diagnostics (BJDX) Amortizatization of Intangibles (2020 - 2023)
Bluejay Diagnostics (BJDX) posted Amortizatization of Intangibles of $40327.0 for Q2 2023, little changed sequentially from $40328.0 in Q1 2023, and up 4.11% YoY from $38734.0 in Q2 2022.
Bluejay Diagnostics (BJDX) Amortizatization of Intangibles (2020 - 2023) Analysis & Trends
Bluejay Diagnostics has reported Amortizatization of Intangibles for 4 years, with the latest figure at $40327.0 in Q2 2023.
- Quarterly Amortizatization of Intangibles rose 4.11% year-over-year to $40327.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $147627.0 (up 363.78% YoY) and the FY2022 annual result came in at $145837.0, up 536.87% from the prior year.
- Amortizatization of Intangibles was little changed at $40327.0 in Q2 2023 per BJDX's latest filing, from $40328.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $40328.0 in Q1 2023 and troughed at -$122938.0 in Q4 2021.
- A 4-year average of -$2189.6 and a median of $29167.0 in 2020 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2021 and 2023: Amortizatization of Intangibles sank 77.7% in 2021, then jumped 42.81% in 2023.
- Over 4 years, Amortizatization of Intangibles stood at -$69183.0 in 2020, then plunged by 77.7% to -$122938.0 in 2021, then jumped by 131.51% to $38734.0 in 2022, then gained by 4.11% to $40327.0 in 2023.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $40327.0, $40328.0, and $38734.0 for Q2 2023, Q1 2023, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | 22,204.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 40,327.00 |
| Jun 30, 2023 | 40,327.00 |
| Mar 31, 2023 | 40,328.00 |
| Mar 31, 2023 | 40,328.00 |
| Jun 30, 2022 | 38,734.00 |
| Jun 30, 2022 | 38,734.00 |
| Mar 31, 2022 | 28,238.00 |
| Mar 31, 2022 | 28,238.00 |
| Dec 31, 2021 | -122,938.00 |
| Dec 31, 2021 | -122,938.00 |
| Dec 31, 2020 | -69,183.00 |
| Dec 31, 2020 | -69,183.00 |
| Sep 30, 2020 | 29,167.00 |
| Sep 30, 2020 | 29,167.00 |